文献速递淋巴瘤白血病

小鼠EBI2过表达导致B1 B细胞扩增和慢性淋巴细胞白血病样B细胞恶性肿瘤

EBI2 overexpression in mice leads to B1 B-cell expansion and chronic lymphocytic leukemia-like B-cell malignancies.
PubMed 文献 · Blood · 2016-12-21

研究在小鼠B细胞中靶向表达人EBI2,发现其减少生发中心依赖免疫应答、降低总IgM和IgG水平、增加增殖并上调癌基因,导致CD5+ B1a B细胞亚群异常扩增(出生后4天即出现)、迟发性淋巴癌和早死,与CLL患者所见高度相似,提示EBI2促进B细胞恶性肿瘤。

要点

  • B细胞靶向表达人EBI2的小鼠生发中心依赖免疫应答减少,总IgM和IgG水平降低。
  • hEBI2过表达导致CD5+ B1a B细胞亚群异常扩增,出生后4天即出现。
  • hEBI2过表达小鼠发生迟发性淋巴癌和早死,与CLL患者所见高度相似。

核心结论

  • 小鼠B细胞靶向过表达人EBI2导致CD5+ B1a B细胞异常扩增、迟发性淋巴癌和早死,与CLL患者所见高度相似,提示EBI2是B细胞恶性肿瘤的促进因子。

研究设计与样本

  • 研究采用B细胞靶向表达人EBI2(hEBI2)的小鼠模型,观察免疫应答、B细胞亚群及淋巴癌发生。

主要发现

  • hEBI2过表达小鼠生发中心依赖免疫应答减少,总IgM和IgG水平降低。
  • hEBI2过表达小鼠B细胞增殖增加并上调细胞癌基因。
  • hEBI2过表达小鼠CD5+ B1a B细胞亚群异常扩增,出生后4天即出现。
  • hEBI2过表达小鼠发生迟发性淋巴癌并早死。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Human and mouse chronic lymphocytic leukemia (CLL) develops from CD5+ B cells that in mice and macaques are known to define the distinct B1a B-cell lineage. B1a cells are characterized by lack of germinal center (GC) development, and the B1a cell population is increased in mice with reduced GC formation. As a major mediator of follicular B-cell migration, the G protein-coupled receptor Epstein-Barr virus-induced gene 2 (EBI2 or GPR183) directs B-cell migration in the lymphoid follicles in response to its endogenous ligands, oxysterols. Thus, upregulation of EBI2 drives the B cells toward the extrafollicular area, whereas downregulation is essential for GC formation. We therefore speculated whether increased expression of EBI2 would lead to an expanded B1 cell subset and, ultimately, progression to CLL. Here, we demonstrate that B-cell-targeted expression of human EBI2 (hEBI2) in mice reduces GC-dependent immune responses, reduces total immunoglobulin M (IgM) and IgG levels, and leads to increased proliferation and upregulation of cellular oncogenes. Furthermore, hEBI2 overexpression leads to an abnormally expanded CD5+ B1a B-cell subset (present as early as 4 days after birth), late-onset lymphoid cancer development, and premature death. These findings are highly similar to those observed in CLL patients and identify EBI2 as a promoter of B-cell malignancies.

来源:Blood,查看原文。版权归原作者所有。

引用

  1. Niss Arfelt K, Barington L, Benned-Jensen T, et al. EBI2 overexpression in mice leads to B1 B-cell expansion and chronic lymphocytic leukemia-like B-cell malignancies. Blood. 2016. PMID: 28003273. doi:10.1182/blood-2016-02-697185

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。